These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 9855030)

  • 21. Nonparametric tests for comparing umbrella pattern treatment effects with a control in a randomized block design.
    Lim DH; Wolfe DA
    Biometrics; 1997 Jun; 53(2):410-8. PubMed ID: 9235118
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nonparametric sequential monitoring of longitudinal trials.
    Bogowicz P; Gombay E; Heo G
    Stat Med; 2010 Oct; 29(24):2469-79. PubMed ID: 20690108
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dose response studies. I. Some design considerations.
    Ruberg SJ
    J Biopharm Stat; 1995 Mar; 5(1):1-14. PubMed ID: 7613556
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Analysis of a within-subject design with covariates.
    Patel HI
    J Biopharm Stat; 1997 Jul; 7(3):369-81. PubMed ID: 9252831
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Poisson regression analysis in clinical research.
    Kianifard F; Gallo PP
    J Biopharm Stat; 1995 Mar; 5(1):115-29. PubMed ID: 7613557
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Use of simulation to compare the performance of minimization with stratified blocked randomization.
    Toorawa R; Adena M; Donovan M; Jones S; Conlon J
    Pharm Stat; 2009; 8(4):264-78. PubMed ID: 18756580
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sample size of randomized double-blind trials 1976-1991.
    Mulward S; Gotzsche PC
    Dan Med Bull; 1996 Feb; 43(1):96-8. PubMed ID: 8906985
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A reviewer's perspective on multiple endpoint issues in clinical trials.
    Huque MF; Sankoh AJ
    J Biopharm Stat; 1997 Nov; 7(4):545-64. PubMed ID: 9358328
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Drop-outs and a random regression model.
    Overall JE
    J Biopharm Stat; 1997 Jul; 7(3):383-402. PubMed ID: 9252832
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The alpha and beta errors in randomized trials.
    Lilford RJ; Johnson N
    N Engl J Med; 1990 Mar; 322(11):780-1. PubMed ID: 2308613
    [No Abstract]   [Full Text] [Related]  

  • 31. Changes in surrogate outcomes can be translated into clinical outcomes using a Monte Carlo model.
    van Walraven C; Oake N; Coyle D; Taljaard M; Forster AJ
    J Clin Epidemiol; 2009 Dec; 62(12):1306-15. PubMed ID: 19545974
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reporting statistical information in medical journal articles.
    Cummings P; Rivara FP
    Arch Pediatr Adolesc Med; 2003 Apr; 157(4):321-4. PubMed ID: 12695224
    [No Abstract]   [Full Text] [Related]  

  • 33. Power evaluation of various modified Bonferroni procedures by a Monte Carlo study.
    Morikawa T; Terao A; Iwasaki M
    J Biopharm Stat; 1996 Jul; 6(3):343-59. PubMed ID: 8854237
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A method for the analysis of repeated binary outcomes in randomized clinical trials with non-compliance.
    Sato T
    Stat Med; 2001 Sep 15-30; 20(17-18):2761-74. PubMed ID: 11523081
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Testing homogeneity of the risk ratio in stratified noncompliance randomized trials.
    Lui KJ
    Contemp Clin Trials; 2007 Sep; 28(5):614-25. PubMed ID: 17409026
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Application of rank analysis of covariance methods to analysis of multiple anatomical regions with treatment for seborrheic dermatitis.
    Ramaswamy R; Koch GG; Amara IA
    J Biopharm Stat; 1997 Jul; 7(3):403-16. PubMed ID: 9252833
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Appropriate analysis and reporting of cluster randomised trials.
    Goodacre S
    Emerg Med J; 2005 Feb; 22(2):156; author reply 156. PubMed ID: 15662078
    [No Abstract]   [Full Text] [Related]  

  • 38. Effect of investigator bias on the power and level of the two-sample Z-test.
    DeLucca P; Raghavarao D; Altan S
    J Biopharm Stat; 1999 May; 9(2):279-88. PubMed ID: 10379694
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Methodology and quality of immunotherapy trials.
    Malling HJ
    Allergy; 2004 May; 59(5):482-4. PubMed ID: 15080827
    [No Abstract]   [Full Text] [Related]  

  • 40. Blinded trials taken to the test: an analysis of randomized clinical trials that report tests for the success of blinding.
    Hróbjartsson A; Forfang E; Haahr MT; Als-Nielsen B; Brorson S
    Int J Epidemiol; 2007 Jun; 36(3):654-63. PubMed ID: 17440024
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.